BPCE
ELV icon

Bank Pictet & Cie (Europe)’s Elevance Health ELV Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605K Buy
1,564
+111
+8% +$41.2K 0.01% 162
2026
Q1 		$425K Buy
1,453
+228
+19% +$74.9K 0.01% 175
2025
Q4 		$429K Buy
1,225
+45
+4% +$15.2K 0.01% 166
2025
Q3 		$381K Buy
1,180
+251
+27% +$78.1K 0.01% 173
2025
Q2 		$361K Buy
929
+304
+49% +$122K 0.01% 167
2025
Q1 		$272K Buy
+625
New +$251K 0.01% 153

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s ELV Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its Elevance Health (ELV) stake by 7.6% in Q2 2026, buying an estimated $41.2K and bringing the position to 1,564 shares worth $605K. The position accounts for 0.01% of the portfolio, ranked #162.

Bank Pictet & Cie (Europe) first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,033 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 1,564 shares of Elevance Health worth $605K as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 111 Elevance Health shares in Q2 2026, an estimated $41.2K.
  • Elevance Health made up 0.01% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #162 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.